Navigation Links
Cell Therapeutics, Inc. Announces Institutional Investors Purchase $20 Million of Preferred Stock and Warrants
Date:12/8/2011

shares of common stock and have no voting rights on general corporate matters.

The closing of the offering is expected to occur on December 13, 2011, at which time the Company will receive the cash proceeds and deliver the securities.

Rodman & Renshaw, LLC, a wholly-owned subsidiary of Rodman & Renshaw Capital Group, Inc., (Nasdaq: RODM), acted as the exclusive placement agent for the offering. Trout Capital LLC provided financial advisory services.

A shelf registration statement relating to the shares of Series 14 Preferred Stock and warrants issued in the offering (and the shares of common stock issuable upon conversion of the Series 14 Preferred Stock and exercise of the warrants) has been filed with the Securities and Exchange Commission (the "SEC"). A prospectus supplement under Rule 424 of the Securities Act of 1933, as amended, relating to the offering will be filed with the SEC. Copies of the prospectus supplement and accompanying prospectus may be obtained directly from the Company by contacting the Company at the following address: Cell Therapeutics, Inc., 501 Elliott Avenue West, Suite 400, Seattle, Washington 98119. This press release does not constitute an offer to sell or a solicitation of an offer to buy the Series 14 Preferred Stock or warrants (or the shares of common stock issuable upon conversion of the Series 14 Preferred Stock and exercise of the warrants). No offer, solicitation or sale will be made in any jurisdiction in which such offer, solicitation or sale is unlawful.

This press release includes forward-looking statements that involve a number of risks and uncertainties, the outcome of which could materially and/or adversely affect actual future results and the trading prices of the Company's securities. The risks and uncertainties include the risk that the purchase and sale of the Series 14 Preferred Stock
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cell Therapeutics, Inc. (CTI) to Present at 10th Annual BIO Investor Forum
2. Womens Health Therapeutics, Analysis and Market Forecasts to 2016 - High Unmet Need will Drive the Uptake of Novel Drugs in the Menopause and Osteoporosis Markets
3. Reed V. Tuckson, M.D., Executive Vice President and Chief of Medical Affairs at UnitedHealth Group, Joins Board of Directors of Cell Therapeutics, Inc. (CTI)
4. Intrinsic Therapeutics, Inc. Names Cary P. Hagan as President & CEO
5. Rare Disease Therapeutics, Inc. Selects Accredo Health Group to Distribute AnascorpĀ® for the Treatment of Centruroides Scorpion Sting Envenomation
6. Prefilled Syringes: Devices, Therapeutics, Players, Markets and Prospects
7. Dry Powder Inhalation: Devices, Drugs, Therapeutics, Markets and Forecasts
8. Cell Therapeutics, Inc. (CTI) Reports Reduction in Operating Expenses and Net Losses for Second Quarter and First Half 2011 Compared to 2010, and Advances In Bringing Pixantrone to Market
9. Cell Therapeutics, Inc. Announces Institutional Investors Purchase $30 Million of Preferred Stock and Warrants
10. Cell Therapeutics, Inc. Reports Outcome of Special Meeting of Shareholders
11. Serina Therapeutics, Inc. Closes $9.5 Million Financing Round
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014  A novel wearable injector slightly larger ... painless for patients to self-inject prescription drugs in the large ... cancer, blood diseases, autoimmune deficiencies, and genetic disorders.  ... to $220B by 2018, according to analysts.   Many of these ...
(Date:1/14/2014)... , Jan. 14, 2014 The Brandeis Medical Center, led by ... a premier and affordable laser tattoo removal experience with the ... focus is in providing high quality cosmetic services with cutting edge ... " Southern California has seen a dramatic ...
(Date:1/14/2014)... PLYMOUTH, Minn. , Jan. 14, 2014   NuAire , a ... come to agreement with Hitachi Koki of ... centrifuges in North America . NuAire will utilize ... and Canada to offer assistance ...
Breaking Medicine Technology:Enable Injections Presents A New Class of Injectors for Drug Delivery at PEPTalk, Drug Delivery Partnership Meetings 2Beverly Hills Physician Features Tattoo Removal with the Astanza Duality Laser, Offers $99 Special 2NuAire announces sales and service of Hitachi Koki centrifuges in North America 2
... 2011 The American Association for Homecare strongly endorses ... Medicare "competitive" bidding program for home medical equipment and ... introduced by Congressmen Glenn Thompson (R-Pa.) and Jason Altmire ... "Fairness in Medicare Bidding Act."   ...
... 2011 AstraZeneca today announced enrolment of the first ... an oral peripherally-acting opioid antagonist being investigated for the ... programme is designed to investigate the safety and efficacy ... constipation, a common side effect of prescription opioids when ...
Cached Medicine Technology:Home Medical Equipment Group Supports Bipartisan Bill to Repeal the Controversial Medicare 'Competitive' Bidding Program for Homecare 2Home Medical Equipment Group Supports Bipartisan Bill to Repeal the Controversial Medicare 'Competitive' Bidding Program for Homecare 3AstraZeneca Initiates Phase III Clinical Programme Evaluating NKTR-118 for Treatment of Opioid-Induced Constipation 2AstraZeneca Initiates Phase III Clinical Programme Evaluating NKTR-118 for Treatment of Opioid-Induced Constipation 3
(Date:4/24/2014)... research at UT Southwestern Medical Center previously discovered that ... the adult heart lacks this ability. New research by ... loses its incredible regenerative capability in adulthood, and the ... oxygen. It is well-known that a major function of ... body. But at the same time, oxygen is a ...
(Date:4/24/2014)... with an antimicrobial peptide could help to lower the risk ... Optometry and Vision Science , official journal of the ... published by Lippincott Williams & Wilkins , a part ... and now humans support the biocompatibility and safety of lenses ... research by Debarun Dutta, B.Optom, of The University of New ...
(Date:4/24/2014)... Changes in managing patients before, during and after colorectal ... readmission rates, according to researchers who led a study ... practice, called enhanced recovery, is easier on patients before ... evacuation that are typically prescribed. After surgery, patients are ... possible, leading to faster recoveries. , Among findings published ...
(Date:4/24/2014)... new Institute for Biomedical Sciences at Georgia State ... grant to develop novel therapeutics against Respiratory Syncytial ... Eunice Kennedy Shriver National Institute Of Child Health ... Health will support Plemper,s drug development goals of ... distinct alternative compound. , Infections by RSV, a ...
(Date:4/24/2014)... terminology, and the relevance of palliation in advanced ... randomized controlled trials (RCTs). This is the result ... Quality and Efficiency in Health Care (IQWiG), which ... Together with external experts, IQWiG analysed studies on ... malignant melanoma, and pancreatic cancer. For this purpose, ...
Breaking Medicine News(10 mins):Health News:Oxygen diminishes the heart's ability to regenerate, researchers discover 2Health News:Study supports safety of antimicrobial peptide-coated contact lenses 2Health News:Study supports safety of antimicrobial peptide-coated contact lenses 3Health News:New approach for surgery patients cuts hospital stays and costs 2Health News:New approach for surgery patients cuts hospital stays and costs 3Health News:Palliation is rarely a topic in studies on advanced cancer 2Health News:Palliation is rarely a topic in studies on advanced cancer 3
... found that a new combination of medications designed ... myeloma for 76 percent of patients who had ... of an ongoing clinical trial evaluating pomalidomide, a ... presented today at the 50th Annual Meeting of ...
... better than women at tasks that require rotating an object ... and UCLA have discovered that this type of spatial skill ... as young as 5 months old. , ... studies have shown that adult men have an advantage in ...
... tax, leads to higher premiums for families and employers , ... the full proposal: http://www.ahip.org/content/default.aspx?docid=25216 , ... and Medicaid reimbursements to hospitals and physicians lead to significantly ... a study released today by Milliman Inc. The report ...
... Study Utilizing Pathwork Tissue of Origin Test , ... molecular diagnostics company focused on oncology, announced today a collaboration with ... St Thomas, will be the first hospitals in the United Kingdom ... Test, which aids in the diagnosis of hard-to-identify tumors. , ...
... Critical Need for Deep Vein Thrombosis (DVT) Prophylaxis in Hospitals ... Dec. 9 Eisai Inc., in coordination with the North ... This new award provides national recognition to hospitals that ... potentially fatal complications. , , ...
... 9th Declared Second Annual Children,s Flu Vaccination Day to Help Increase Vaccination Rates and ... WASHINGTON, Dec. 9 , , To view the ... , News Facts , ... Families Fighting Flu (FFF) , together with the Centers ...
Cached Medicine News:Health News:Drug combination improves or stabilizes disease for relapsed multiple myeloma patients 2Health News:Psychologists report that a gender gap in spatial skills starts in infancy 2Health News:Psychologists report that a gender gap in spatial skills starts in infancy 3Health News:Consumers and Employers Paying Almost $90 Billion Due to Under-Payments to Hospitals and Physicians by Medicare and Medicaid 2Health News:Consumers and Employers Paying Almost $90 Billion Due to Under-Payments to Hospitals and Physicians by Medicare and Medicaid 3Health News:Consumers and Employers Paying Almost $90 Billion Due to Under-Payments to Hospitals and Physicians by Medicare and Medicaid 4Health News:Consumers and Employers Paying Almost $90 Billion Due to Under-Payments to Hospitals and Physicians by Medicare and Medicaid 5Health News:Pathwork Diagnostics Collaborates With Guy's and St Thomas' on Tissue of Origin Test Validation in the UK 2Health News:Pathwork Diagnostics Collaborates With Guy's and St Thomas' on Tissue of Origin Test Validation in the UK 3Health News:Eisai Inc. and the North American Thrombosis Forum (NATF)* Introduce the DVTeamCare(TM) Hospital Award and Call for Nominations 2Health News:Eisai Inc. and the North American Thrombosis Forum (NATF)* Introduce the DVTeamCare(TM) Hospital Award and Call for Nominations 3Health News:Photo: Families Fighting Flu and CDC Encourage Parents to Vaccinate Kids Against Flu 2Health News:Photo: Families Fighting Flu and CDC Encourage Parents to Vaccinate Kids Against Flu 3
... The TC-PLUS Solution tricompartmental total knee prosthesis ... knee arthroplasty. State-of-the-art design and manufacturing technologies ... optimum biomechanical function as well as a ... tibial insert to keep wear to a ...
... Proven Knee System is a long term, ... design. Available in both posterior stabilized and ... Knee System provides the flexibility needed to ... and ease of identification keeps the user ...
... FluoroNav Virtual Fluoroscopy software ... Technologies has incorporated ease ... technology features such as ... three-dimensional models of image ...
... T.L.I.F. SG Instruments are the next evolution ... comprehensive and functionally sound instruments.. The T.L.I.F. ... disc removal and disc preparation instruments designed ... Excellent design, a wide range of instrument ...
Medicine Products: